Pfizer

PFE · NYSE · USD

$28.24−1.00%−$0.28

Close · October 1, 2026

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total revenue	62,579	63,627	59,554	101,175	81,288	41,651	40,905	40,825	52,546	52,824
Cost of revenue	15,140	17,191	23,989	34,097	30,686	8,385	7,847	8,872	10,826	11,918
Gross profit	47,439	46,436	35,565	67,078	50,602	33,266	33,058	31,953	41,720	40,906
Selling, general and administrative	12,964	14,771	13,836	12,200	9,562	11,418	12,766	12,149	14,606	14,894
Research and development	10,437	10,822	10,679	11,426	10,360	8,709	7,721	7,713	7,645	7,858
Operating income	19,164	15,557	6,317	39,843	26,980	9,791	8,142	7,355	14,711	14,098
EBIT	19,164	15,557	6,317	39,843	26,980	9,791	8,142	7,355	14,711	14,098
EBITDA	25,718	22,551	12,575	44,871	32,084	14,455	13,857	13,467	20,889	19,648
Interest expense	2,671	3,091	2,209	1,238	1,291	1,449	1,573	1,316	1,270	1,186
Pre-tax income	7,521	8,023	1,058	34,729	24,310	7,036	11,320	3,595	12,304	8,353
Income tax	-266	-28.0	-1,115	3,328	1,852	370	583	-266	-9,049	1,123
Net income	7,771	8,031	2,119	31,372	21,979	9,159	16,026	11,153	21,308	7,215
Net income to common shareholders	7,746	8,020	2,134	31,366	22,413	6,630	10,707	3,824	21,305	7,198
Basic EPS	1.36	1.42	0.38	5.59	4.00	1.19	1.92	0.65	3.57	1.18
Diluted EPS	1.36	1.41	0.37	5.47	3.93	1.18	1.89	0.64	3.52	1.17
Average shares (basic)	5,683	5,664	5,643	5,608	5,601	5,555	5,569	5,872	5,970	6,089
Average shares (diluted)	5,713	5,700	5,709	5,733	5,708	5,632	5,675	5,977	6,058	6,159
Dividend per share	1.72	1.68	1.64	1.60	1.56	1.52	1.44	1.36	1.28	1.20